Benzinga | Oct 28, 2020 08:23AM EDT

Raymond James Maintains Outperform on DexCom, Lowers Price Target to $438

Raymond James maintains DexCom (NASDAQ:DXCM) with a Outperform and lowers the price target from $450 to $438.